RA and Gouty arthritis Flashcards

1
Q

Biomarkers for RA diagnosis

A

Anti-CCPs and RF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which of the ff is TRUE about RA?

A. Result from inflammation of the joints, tendons, and bursae.
B. Early morning joint stiffness lasting less than 1 hr
C. Earliest involved joints are small joints of hands and feet
D. Two of the options
E. All of the options

A

D. Two of the options

Early morning joint stiffness lasting MORE THAN 1HR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Frequent hallmark of RA

A

Flexor tendon tenosynovitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hyperextension of the PIP joint with flexion of the DIP joint

A

Swan-neck deformity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Flexion of the PIP joint with hyperextension of the DIP joint

A

Boutonniere deformity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Subluxation of MCP joint with hyperextension of the first IP

A

Z-line deformity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Subluxation of the distal ulna

A

Piano-key movement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The most frequent site of cardiac involvement in RA is the __________

A. Endocardium
B. Myocardium
C. Pericardium
D. Any of the options

A

C. Pericardium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cardiomyopathy, a clinically important manifestation of RA can only be identified by which of the ff?

A. Echocardiography
B. CT scan
C. MRI
D. Any of the options

A

D. Any of the options

Echocardiography and MRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

The most common valvular abnormality in RA is ________

A. Aortic stenosis
B. Mitral regurgitation
C. Tricuspid regurgitation
D. Any of the options

A

B. Mitral regurgitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

The most common pulmonary manifestation of RA is ________

A. interstitial lung disease
B. pulmonary vasculitis
C. pleuritis
D. pleural effusion

A

C. Pleuritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

The most common hematologic abnormality in RA is _________

A. Anemia
B. Neutropenia
C. Leukemia
D. Lymphoma

A

A. Anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The most common cause of death in RA patients is ________

A. Pulmonary disease
B. Hematologic disease
C. Cardiovascular disease
D. Two of the options
E. All of the options
A

C. Cardiovascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The gene to confer the greatest risk of RA is _________

A

HLA-DRB1 gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The most reproducible environmental factor linked to RA is _________

A

Cigarette smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Citrullination involves the conversion of citrulline from what amino acid?

A. Arginine
B. Alanine
C. Tryptophan
D. Valine

A

A. Arginine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the pathologic hallmarks of RA?

A

Synovial inflammation and proliferation, focal bone erosions, and thinning of articular cartilage.

18
Q

Chronic inflammation leads to ___________

A. Synovial lining hyperplasia
B. Formation of pannus
C. Nephritis
D. Two of the options
E. All of the options
A

D. Two of the options

Synovial lining hyperplasia
Formation of PANNUS - thickened cellular membrane containing fibroblast-like synoviocytes and granulation-reactive fibrovascular tissuie

19
Q

The structural damage to the mineralized cartilage and subchondral bone is mediated by the _______

A. Osteoclast
B. Osteoblast
C. Osteocytes
D. Any of the options

A

A. Osteoclast

-multinucleated giant cells, identified by expression of CD68, and appear at the pannus-bone interface where they form resorption lacunae

20
Q

Immunoglobulin which is most frequently measured by laboratories and found in 75-80% of the patients

A

IgM

21
Q

Synovial fluid WBC count in RA

A

5000 - 50,000

2000 - noninflammatory (OA)

22
Q

Most useful confirmatory lab test for inflammatory arthritis such as RA

A

Synovial fluid analysis

23
Q

In plain radiography, the initial finding is ___________

A. Periarticular osteopenia
B. Soft tissue swelling
C. Symmetric joint space loss
D. Subchondral erosions

A

A. Periartricular osteopenia

24
Q

What part of the feet is often targeted first in RA?

A. 1st MTP
B. 2nd MTP
C. 3rd MTP
D. 4th MTP
E. 5th MTP
A

A. 1st MTP

25
Q

What imaging technique offers the greatest sensitivity for detecting synovitis and joint effusions, as well as early bone and bone marrow changes?

A

MRI

26
Q

What is the most common cause of death in RA patients?

A. Infection
B. MI
C. Ischemic heart disease
D. Pneumonia
E. Any of the options
A

C. Ischemic heart disease

27
Q

DMARD of first choice for the treatment of RA

A

Methotrexate

28
Q

Osteoporosis ranks as an important long-term complication of chronic use of what drug?

A

Prednisone

29
Q

Which of the following is/are used to reduce the signs and symptoms of RA, slow radiographic progression of joint damage, and improve physical function and quality of life?

A. Infliximab
B. Adalimumab
C. Etanercept
D. Two of the options
E. All of the above
A

E. All of the above

30
Q

This drug is a chimeric monoclonal antibody directed against CD20, a molecule expressed by most mature B lymphocytes

A

Rituximab

31
Q

What drugs are considered as oral triple therapy for RA?

A. Methotrexate + Leflunomide + Tofacitinib
B. Methotrexate + Sulfasalazine + Hydroxychloroquine
C. Methotrexate + Anankira + Infliximab
D. Methotrexate + Abatacept + Rituximab

A

B. Methotrexate, Sulfasalazine, and hydroxychloroquine (oral triple therapy)

32
Q

Which of the following is TRUE about Gout?

A. Affects middle-aged man and postmenopausal women
B. Results from increased body pool of calcium pyrophosphate with hyperuricemia
C. Characterized by episodic acute or chronic arthritis
D. Two of the options
E. All of the options

A

D. Two of the options

Results from increase body pool of urate with hyperuricemia

33
Q

Most common early clinical manifestation of gout.

A

Acute arthritis

34
Q

Which of the following may precipitate acute gouty arthritis?

A. Dietary excess
B. Surgery
C. Excessive ethanol ingestion
D. Two of the options
E. All of the options
A

E. All of the options

Several events may precipitate acute gouty arthritis:
dietary excess, trauma, surgery, excessive ethanol ingestion, hypouricemic therapy, and serious medical illnesses such as myocardial infarction
and stroke.

35
Q

Best drug to lower serum urate in overproducers, urate stone formers, and patients with renal disease.

A

Allopurinol

36
Q

This drug reduces neutrophil mediated inflammatory

response by blocking the beta tubulin polymerization→ prevents the migration of neutrophils into the inflamed area

A

Colchicine

37
Q

This drug is a urate oxidase enzyme, third-line and newest urate-lowering therapy to be approved for
the treatment of refractory chronic gout.

A. Febuxostat
B. Colchicine
C. Pegloticase
D. Any of the options

A

C. Pegloticase

38
Q

This drug is a potent and selective inhibitor of xanthine oxidase, thereby reducing the formation of xanthine and uric acid without affecting other enzymes in the purine or pyrimidine metabolic pathway.

A. Allopurinol
B. Febuxostat
C. Probenecid
D. Any of the options

A

B. Febuxostat

39
Q

This uricosuric drug/s are employed to
decrease the body pool of urate in patients with tophaceous gout or in those with increasingly frequent gouty attacks.

A. Probenecid
B. Sulfinpyrazone
C. Allopurinol
D. Colchicine
E. Any of the options
A

E. Any of the options

Probenecid and Sulfinpyrazone

40
Q

This stage of gout presents an imaging which shows characteristic juxta articular bone and loss of
joint space

A

Chronic tophaceous gout